Richard L. Gabriel, Director at Predictive Oncology Inc. (POAI), bought 3,000 shares at $0.62 ($2K) on 2019-08-23, disclosed to the SEC on 2019-08-26.
Open-market purchase of $2k POAI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.59 | 2,200 | $1K | 72.4% |
| 2 | $0.62 | 800 | $496 | 27.6% |
| Total | $0.60 avg | 3,000 | $2K | 100% |
| Filing → |
| POAI | BUY | 2019-09-06 | $920 | — | Filing → |
| AIPT | BUY | 2018-12-12 | $1K | — | Filing → |
| AIPT | BUY | 2018-11-29 | $2K | — | Filing → |